Jan Eickhoff

3.0k total citations · 1 hit paper
38 papers, 1.8k citations indexed

About

Jan Eickhoff is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Jan Eickhoff has authored 38 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Epidemiology and 12 papers in Oncology. Recurrent topics in Jan Eickhoff's work include Cytomegalovirus and herpesvirus research (12 papers), Cancer-related Molecular Pathways (6 papers) and Herpesvirus Infections and Treatments (6 papers). Jan Eickhoff is often cited by papers focused on Cytomegalovirus and herpesvirus research (12 papers), Cancer-related Molecular Pathways (6 papers) and Herpesvirus Infections and Treatments (6 papers). Jan Eickhoff collaborates with scholars based in Germany, Norway and United States. Jan Eickhoff's co-authors include Bert Klebl, Peter Habenberger, Axel Choidas, Sascha Menninger, Alf Herzig, Renate Krüger, Garth L. Burn, Gabriel Sollberger, Peter Nußbaumer and Raffaella Di Lucrezia and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Molecular and Cellular Biology.

In The Last Decade

Jan Eickhoff

37 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Gasdermin D plays a vital role in the generation of neutrophil extracellular traps

2018 571 citations Gabriel Sollberger, Axel Choidas et al. Science Immunology profile →

Peers

Countries citing papers authored by Jan Eickhoff

Since Specialization

Citations

This map shows the geographic impact of Jan Eickhoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Eickhoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Eickhoff more than expected).

Fields of papers citing papers by Jan Eickhoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Eickhoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Eickhoff. The network helps show where Jan Eickhoff may publish in the future.

Co-authorship network of co-authors of Jan Eickhoff

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Eickhoff. A scholar is included among the top collaborators of Jan Eickhoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Eickhoff. Jan Eickhoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of a live cell assay for real-time monitoring the interactions between the Hippo pathway components 14-3-3 and TAZ 2024 ·SLAS DISCOVERY ·(unknown), (unknown), (unknown), Bert Klebl, Jan Eickhoff, Christian Ottmann	0
2	An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity 2024 ·Pharmaceutics ·(unknown), Sabrina Wagner, Martin Schütz, (unknown), (unknown), Jaeseung Kim, (unknown), (unknown), Julia Tillmanns, Christina Wangen, Friedrich Hahn, Benedikt B. Kaufer, Frank Neipel, Jan Eickhoff, Bert Klebl, Kiyean Nam, Manfred Marschall	6
3	Assessment of Covalently Binding Warhead Compounds in the Validation of the Cytomegalovirus Nuclear Egress Complex as an Antiviral Target 2023 ·Cells ·Julia Tillmanns, (unknown), Eva Maria Borst, (unknown), Jan Eickhoff, Bert Klebl, Sabrina Wagner, Christina Wangen, Friedrich Hahn, Eileen Socher, Manfred Marschall	8
4	IFNα primes cancer cells for Fusicoccin-induced cell death via 14-3-3 PPI stabilization 2023 ·Cell chemical biology ·(unknown), (unknown), (unknown), Sebastian A. Andrei, (unknown), Yusuke Higuchi, Nobuo Kato, Luc Brunsveld, Michelle R. Arkin, Sascha Menninger, Axel Choidas, (unknown), Bert Klebl, Farnusch Kaschani, Markus Kaiser, Jan Eickhoff, Christian Ottmann	12
5	Combined Treatment with Host-Directed and Anticytomegaloviral Kinase Inhibitors: Mechanisms, Synergisms and Drug Resistance Barriers 2023 ·Pharmaceutics ·(unknown), (unknown), Jan Eickhoff, Sabrina Wagner, (unknown), William C. Chang, Peter A. Barry, Stipan Jonjić, T. Rovis, Manfred Marschall	8
6	Characterization of the Antibacterial Activity of Quinone-Based Compounds Originating from the Alnumycin Biosynthetic Gene Cluster of a Streptomyces Isolate 2023 ·Antibiotics ·(unknown), (unknown), (unknown), Christian Rückert, Tobias Busche, Alexander Wolf, Jan Eickhoff, Bert Klebl, Jörn Kalinowski, Julia E. Bandow	3
7	A highly selective purine-based inhibitor of CSF1R potently inhibits osteoclast differentiation 2023 ·European Journal of Medicinal Chemistry ·(unknown), Jan Eickhoff, Bert Klebl, Anke Unger, Joanna Boros, Axel Choidas, (unknown), (unknown), Geir Bjørkøy, Eirik Sundby, Bård Helge Hoff	7
8	Combinatorial Drug Treatments Reveal Promising Anticytomegaloviral Profiles for Clinically Relevant Pharmaceutical Kinase Inhibitors (PKIs) 2021 ·International Journal of Molecular Sciences ·(unknown), (unknown), Lisa Seyler, Christina Wangen, Luca D. Bertzbach, Andelé M. Conradie, Benedikt B. Kaufer, Sabrina Wagner, Detlef Michel, Jan Eickhoff, Svetlana B. Tsogoeva, Tobias Bäuerle, Friedrich Hahn, Manfred Marschall	27
9	Kinase Chemodiversity from the Arctic: The Breitfussins 2019 ·Journal of Medicinal Chemistry ·(unknown), Jeanette H. Andersen, Annette Bayer, (unknown), (unknown), Kåre B. Jørgensen, Magne O. Sydnes, (unknown), Matthias Baumann, Uwe Koch, Bert Klebl, Jan Eickhoff, Bengt Erik Haug, Johan Isaksson, Espen Hansen	25
10	Gasdermin D plays a vital role in the generation of neutrophil extracellular traps breakdown → 2018 ·Science Immunology ·Gabriel Sollberger, Axel Choidas, Garth L. Burn, Peter Habenberger, Raffaella Di Lucrezia, (unknown), Sascha Menninger, Jan Eickhoff, Peter Nußbaumer, Bert Klebl, Renate Krüger, Alf Herzig, Arturo Zychlinsky	571
11	In vivo proof-of-concept for two experimental antiviral drugs, both directed to cellular targets, using a murine cytomegalovirus model 2018 ·Antiviral Research ·Eric Sonntag, Friedrich Hahn, Luca D. Bertzbach, Lisa Seyler, Christina Wangen, Regina Müller, (unknown), (unknown), Matthias Baumann, (unknown), Gunther Zischinsky, Jan Eickhoff, Benedikt B. Kaufer, Tobias Bäuerle, Svetlana B. Tsogoeva, Manfred Marschall	27
12	Modulators of 14-3-3 Protein–Protein Interactions 2017 ·Journal of Medicinal Chemistry ·Loes M. Stevers, Eline Sijbesma, Maurizio Botta, Carol MacKintosh, Tomáš Obšil, Isabelle Landrieu, Ylenia Cau, Andrew J. Wilson, Anna Karawajczyk, Jan Eickhoff, Jeremy Davis, Michael M. Hann, Gavin O’Mahony, Richard G. Doveston, Luc Brunsveld, Christian Ottmann	210
13	Characterization of RON protein isoforms in pancreatic cancer: implications for biology and therapeutics 2016 ·Oncotarget ·Jeffery Chakedis, Randall P. French, Michele Babicky, Dawn Jaquish, Evangeline Mose, Peter T. W. Cheng, (unknown), (unknown), (unknown), (unknown), (unknown), Carsten Schultz‐Fademrecht, Christina Esdar, Oliver Schadt, Jan Eickhoff, Andrew M. Lowy	24
14	Cyclin-dependent Kinases Phosphorylate the Cytomegalovirus RNA Export Protein pUL69 and Modulate Its Nuclear Localization and Activity 2009 ·Journal of Biological Chemistry ·Sabine Rechter, Gillian M. Scott, Jan Eickhoff, (unknown), Sabrina Auerochs, Regina Müller, Thomas Stamminger, William D. Rawlinson, Manfred Marschall	49
15	Protein kinase inhibitors of the quinazoline class exert anti-cytomegaloviral activity in vitro and in vivo 2008 ·Antiviral Research ·Mark R. Schleiss, Jan Eickhoff, Sabrina Auerochs, Martina Leis, (unknown), Sabine Rechter, (unknown), Jodi Anderson, Gillian Scott, William D. Rawlinson, Detlef Michel, Stephan Ensminger, Bert Klebl, Thomas Stamminger, Manfred Marschall	73
16	The Role of RIP2 in p38 MAPK Activation in the Stressed Heart 2008 ·Journal of Biological Chemistry ·Sébastien Jacquet, Yasuhiro Nishino, Sarawut Kumphune, Pierre Sicard, Jane Clark, Koichi S. Kobayashi, Richard A. Flavell, Jan Eickhoff, Matthew Cotten, Michael Marber	33
17	Proteomic Characterization of the Angiogenesis Inhibitor SU6668 Reveals Multiple Impacts on Cellular Kinase Signaling 2005 ·Cancer Research ·Klaus Godl, Oliver J. Gruß, Jan Eickhoff, Josef Wissing, Stephanie Blencke, Martina Weber, (unknown), Dirk Brehmer, László Őrfi, (unknown), Gÿorgý Kéri, Stefan C. Müller, Matthew Cotten, Axel Ullrich, Henrik Daub	84
18	NF-κB activation can mediate inhibition of human cytomegalovirus replication 2005 ·Journal of General Virology ·Jan Eickhoff, Matthew Cotten	26
19	Phosphotyrosine-specific Phosphatase PTP-SL Regulates the ERK5 Signaling Pathway 2002 ·Journal of Biological Chemistry ·Marcus Buschbeck, Jan Eickhoff, (unknown), Axel Ullrich	42
20	Identification of the Binding Site for the Extrahelical Target Base in N 6-Adenine DNA Methyltransferases by Photo-cross-linking with Duplex Oligodeoxyribonucleotides Containing 5-Iodouracil at the Target Position 1999 ·Journal of Biological Chemistry ·(unknown), (unknown), Jan Eickhoff, Georg Lipps, Gerhard Krauss, Elmar G. Weinhold	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact